Employer record no. 24760
RAPT Therapeutics, Inc. (Formerly FLX Bio, Inc.)
US DOL LCA disclosure data, FY2022 to FY2025
Total LCA filings
11
Certified
11
Denied
0
FY2025 filings
2
Filings by fiscal year
Peer rank
#2,375 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2022 | 3 | 3 | 0 | $148,000 | $132,341 |
| FY2023 | 5 | 5 | 0 | $181,944 | $181,489 |
| FY2024 | 1 | 1 | 0 | $223,450 | $170,019 |
| FY2025 | 2 | 2 | 0 | $174,000 | $160,150 |
What they file for
- regulatory operations director$222,6022
- scientist ii, quantitative biology$142,0002
- director, biologics process development$250,0001
- director, regulatory operations$223,4501
- research associate ii, dmpk$98,0001
- research associate ii, quantitative biology$88,7001
- scientist ii, dmpk$160,0001
- senior manager, clinical data management operations$186,8461
Where
- south san francisco, ca9
- lathrop, ca1
- north chelmsford, ma1
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for RAPT Therapeutics, Inc. (Formerly FLX Bio, Inc.) and any other employer they watch.
Certification rate 100.0%How these numbers are computed